Global Longlife Hospital And Research Ltd vs Kovai Medical Center Hospital Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Global Longlife Hospital and Research Ltd is ₹ 12.82 as of 30 Oct 15:30 . The P/E Ratio of Global Longlife Hospital and Research Ltd changed from 25.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Kovai Medical Center & Hospital Ltd changed from 15.5 on March 2021 to 22.5 on March 2026 . This represents a CAGR of 6.41% over 6 years The Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 47.02 crore on March 2023 to ₹ 14.34 crore on March 2026 . This represents a CAGR of -25.69% over 4 yearsThe Market Cap of Kovai Medical Center & Hospital Ltd changed from ₹ 1206 crore on March 2021 to ₹ 5494 crore on March 2026 . This represents a CAGR of 28.75% over 6 years The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 438.65 crore as compare to the Mar '26 revenue of ₹ 421.67 crore. This represent the growth of 4.03% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 131.28 crore as compare to the Mar '26 ebitda of ₹ 119.05 crore. This represent the growth of 10.27% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Kovai Medical Center & Hospital Ltd changed from ₹ 45.75 crore to ₹ 69.09 crore over 9 quarters. This represents a CAGR of 20.11% The Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kovai Medical Center & Hospital Ltd changed from 4.22 % on March 2021 to 6.71 % on March 2026 . This represents a CAGR of 8.04% over 6 years .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad. Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

About Kovai Medical Center & Hospital Ltd

Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital.
Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital. Today, KMCH has grown into a 2,250 bed multi-locational, multi-disciplinary Super specialty hospital, the best and most trusted in Southern India.
The Hospital is equipped with most modern equipments like CT Scanner, Angiograpy equipment with DSA, Operating Microscope, Mammography, C-arm, Color Doppler etc.
There are over 30 Medical Departments and 11 Operation Theatres at the Hospital.

FAQs for the comparison of Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd

Which company has a larger market capitalization, Global Longlife Hospital and Research Ltd or Kovai Medical Center & Hospital Ltd?

Market cap of Global Longlife Hospital and Research Ltd is 13 Cr while Market cap of Kovai Medical Center & Hospital Ltd is 6,354 Cr

What are the key factors driving the stock performance of Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd?

The stock performance of Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd?

As of November 1, 2026, the Global Longlife Hospital and Research Ltd stock price is INR ₹12.82. On the other hand, Kovai Medical Center & Hospital Ltd stock price is INR ₹5808.45.

How do dividend payouts of Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd compare?

To compare the dividend payouts of Global Longlife Hospital and Research Ltd and Kovai Medical Center & Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.